Literature DB >> 31641965

Letter to the Editor re: Confirmation of Specific Binding of the 18-kDa Translocator Protein (TSPO) Radioligand [18F]GE-180: a Blocking Study Using XBD173 in Multiple Sclerosis Normal Appearing White and Grey Matter.

Paolo Zanotti-Fregonara1, Mattia Veronese2, Gaia Rizzo3, Belen Pascual4, Joseph C Masdeu4, Federico E Turkheimer2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31641965     DOI： 10.1007/s11307-019-01433-3

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN： 1536-1632            Impact factor:   3.488


× No keyword cloud information.
  13 in total

1.  In response to: The validity of 18F-GE180 as a TSPO imaging agent.

Authors:  Nathalie L Albert; Marcus Unterrainer; Matthias Brendel; Lena Kaiser; Markus Zweckstetter; Paul Cumming; Peter Bartenstein
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-03-02       Impact factor: 9.236

2.  [¹⁸F]GE-180: a novel fluorine-18 labelled PET tracer for imaging Translocator protein 18 kDa (TSPO).

Authors:  Harry Wadsworth; Paul A Jones; Wai-Fung Chau; Clare Durrant; Naghmeh Fouladi; Joanna Passmore; Dennis O'Shea; Duncan Wynn; Veronique Morisson-Iveson; Amanda Ewan; Mikkel Thaning; Dimitrios Mantzilas; Ingvil Gausemel; Imtiaz Khan; Andrew Black; Michelle Avory; William Trigg
Journal:  Bioorg Med Chem Lett       Date:  2011-12-27       Impact factor: 2.823

3.  TSPO PET with [18F]GE-180 sensitively detects focal neuroinflammation in patients with relapsing-remitting multiple sclerosis.

Authors:  Marcus Unterrainer; C Mahler; L Vomacka; S Lindner; J Havla; M Brendel; G Böning; B Ertl-Wagner; T Kümpfel; V M Milenkovic; R Rupprecht; M Kerschensteiner; P Bartenstein; Nathalie L Albert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-03-09       Impact factor: 9.236

4.  Confirmation of Specific Binding of the 18-kDa Translocator Protein (TSPO) Radioligand [18F]GE-180: a Blocking Study Using XBD173 in Multiple Sclerosis Normal Appearing White and Grey Matter.

Authors:  Sujata Sridharan; Joel Raffel; Ashwini Nandoskar; Chris Record; David J Brooks; David Owen; David Sharp; Paolo A Muraro; Roger Gunn; Richard Nicholas
Journal:  Mol Imaging Biol       Date:  2019-10       Impact factor: 3.488

5.  18F-GE-180: a novel TSPO radiotracer compared to 11C-R-PK11195 in a preclinical model of stroke.

Authors:  Hervé Boutin; Katie Murray; Jesus Pradillo; Renaud Maroy; Alison Smigova; Alexander Gerhard; Paul A Jones; William Trigg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-10-29       Impact factor: 9.236

6.  Comparison of 18F-GE-180 and dynamic 18F-FET PET in high grade glioma: a double-tracer pilot study.

Authors:  Marcus Unterrainer; D F Fleischmann; C Diekmann; L Vomacka; S Lindner; F Vettermann; M Brendel; V Wenter; B Ertl-Wagner; J Herms; C Wetzel; R Rupprecht; J C Tonn; C Belka; P Bartenstein; M Niyazi; Nathalie L Albert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-09-22       Impact factor: 9.236

7.  Head-to-Head Comparison of 11C-PBR28 and 18F-GE180 for Quantification of the Translocator Protein in the Human Brain.

Authors:  Paolo Zanotti-Fregonara; Belen Pascual; Gaia Rizzo; Meixiang Yu; Neha Pal; David Beers; Randall Carter; Stanley H Appel; Nazem Atassi; Joseph C Masdeu
Journal:  J Nucl Med       Date:  2018-01-18       Impact factor: 10.057

8.  TSPO imaging using the novel PET ligand [18F]GE-180: quantification approaches in patients with multiple sclerosis.

Authors:  Lena Vomacka; Nathalie Lisa Albert; Simon Lindner; Marcus Unterrainer; Christoph Mahler; Matthias Brendel; Larissa Ermoschkin; Astrid Gosewisch; Anika Brunegraf; Christopher Buckley; Tania Kümpfel; Rainer Rupprecht; Sibylle Ziegler; Martin Kerschensteiner; Peter Bartenstein; Guido Böning
Journal:  EJNMMI Res       Date:  2017-10-26       Impact factor: 3.138

9.  Determination of [(11)C]PBR28 binding potential in vivo: a first human TSPO blocking study.

Authors:  David R Owen; Qi Guo; Nicola J Kalk; Alessandro Colasanti; Dimitra Kalogiannopoulou; Rahul Dimber; Yvonne L Lewis; Vincenzo Libri; Julien Barletta; Joaquim Ramada-Magalhaes; Aruloly Kamalakaran; David J Nutt; Jan Passchier; Paul M Matthews; Roger N Gunn; Eugenii A Rabiner
Journal:  J Cereb Blood Flow Metab       Date:  2014-03-19       Impact factor: 6.200

10.  Kinetic analysis of the translocator protein positron emission tomography ligand [18F]GE-180 in the human brain.

Authors:  Claire Feeney; Gregory Scott; Joel Raffel; S Roberts; Christopher Coello; Amy Jolly; Graham Searle; A P Goldstone; David J Brooks; Richard S Nicholas; William Trigg; Roger N Gunn; David J Sharp
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-06-28       Impact factor: 9.236
View more
  3 in total

1.  Differential Spatial Distribution of TSPO or Amino Acid PET Signal and MRI Contrast Enhancement in Gliomas.

Authors:  Lena Kaiser; Adrien Holzgreve; Stefanie Quach; Michael Ingrisch; Marcus Unterrainer; Franziska J Dekorsy; Simon Lindner; Viktoria Ruf; Julia Brosch-Lenz; Astrid Delker; Guido Böning; Bogdana Suchorska; Maximilian Niyazi; Christian H Wetzel; Markus J Riemenschneider; Sophia Stöcklein; Matthias Brendel; Rainer Rupprecht; Niklas Thon; Louisa von Baumgarten; Jörg-Christian Tonn; Peter Bartenstein; Sibylle Ziegler; Nathalie L Albert
Journal:  Cancers (Basel)       Date:  2021-12-23       Impact factor: 6.639

2.  In Response to Letter from Fregonara et al. 2019.

Authors:  Richard Nicholas; David Brooks; David Owen
Journal:  Mol Imaging Biol       Date:  2020-02       Impact factor: 3.488

Review 3.  Unravelling neuroinflammation in abusive head trauma with radiotracer imaging.

Authors:  Rahul M Nikam; Xuyi Yue; Vinay V Kandula; Bishnuhari Paudyal; Sigrid A Langhans; Lauren W Averill; Arabinda K Choudhary
Journal:  Pediatr Radiol       Date:  2021-05-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.